Clinical correlates of motor performance during paced postural tasks in Parkinson's disease

D. J. Beckley, V. P. Panzer, M. P. Remler, L. B. Ilog, B. R. Bloem

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Bradykinesia and hypokinesia may both play a significant role in postural instability commonly seen in patients with Parkinson's disease. We investigated which factor -movement time or movement amplitude -is the more significant limiting variable in patients with Parkinson's disease during a paced postural task. We also assessed the effect of antiparkinson medication upon these movement factors and the degree of correlation with changes in clinical performance. Subjects performed paced left-right (L-R) and forward-backward (F-B) continuous weight-shifting tasks at slow, medium and fast paces. Ten Parkinson patients were studied both OFF and ON their usual antiparkinson medication. Ten age-matched healthy controls were also tested and subsequently retested on the same schedule as the patients. Movement times and amplitudes were measured and correlated with clinical changes in UPDRS motor subscores. Parkinson patients performed similar to controls with respect to movement time, but significantly displayed underscaled (reduced) movement amplitude. Movement amplitude improved after antiparkinson medication, but remained significantly less than that of controls. Improvements in L-R movement amplitude correlated with clinical improvements in bradykinesia and postural instability, while improved F-B movement amplitude correlated only with reduced postural instability. We conclude that hypometric movement amplitude, and not abnormal movement time, is the primary abnormality observed in Parkinson patients during a paced postural task. Amplitude underscaling seems antiparkinson medication-dependent and improvement correlates with favorable clinical changes in bradykinesia and postural instability scores.

Original languageEnglish (US)
Pages (from-to)133-138
Number of pages6
JournalJournal of the Neurological Sciences
Volume132
Issue number2
DOIs
StatePublished - 1995

Fingerprint

Hypokinesia
Parkinson Disease
Dyskinesias
Appointments and Schedules
Weights and Measures

Keywords

  • Antiparkinson medication
  • Balance
  • Bradykinesia
  • Parkinson's disease
  • Postural control
  • Rigidity

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology
  • Aging
  • Surgery
  • Developmental Neuroscience
  • Neuroscience(all)

Cite this

Clinical correlates of motor performance during paced postural tasks in Parkinson's disease. / Beckley, D. J.; Panzer, V. P.; Remler, M. P.; Ilog, L. B.; Bloem, B. R.

In: Journal of the Neurological Sciences, Vol. 132, No. 2, 1995, p. 133-138.

Research output: Contribution to journalArticle

Beckley, D. J. ; Panzer, V. P. ; Remler, M. P. ; Ilog, L. B. ; Bloem, B. R. / Clinical correlates of motor performance during paced postural tasks in Parkinson's disease. In: Journal of the Neurological Sciences. 1995 ; Vol. 132, No. 2. pp. 133-138.
@article{1d9235917a56421a87299346174e154b,
title = "Clinical correlates of motor performance during paced postural tasks in Parkinson's disease",
abstract = "Bradykinesia and hypokinesia may both play a significant role in postural instability commonly seen in patients with Parkinson's disease. We investigated which factor -movement time or movement amplitude -is the more significant limiting variable in patients with Parkinson's disease during a paced postural task. We also assessed the effect of antiparkinson medication upon these movement factors and the degree of correlation with changes in clinical performance. Subjects performed paced left-right (L-R) and forward-backward (F-B) continuous weight-shifting tasks at slow, medium and fast paces. Ten Parkinson patients were studied both OFF and ON their usual antiparkinson medication. Ten age-matched healthy controls were also tested and subsequently retested on the same schedule as the patients. Movement times and amplitudes were measured and correlated with clinical changes in UPDRS motor subscores. Parkinson patients performed similar to controls with respect to movement time, but significantly displayed underscaled (reduced) movement amplitude. Movement amplitude improved after antiparkinson medication, but remained significantly less than that of controls. Improvements in L-R movement amplitude correlated with clinical improvements in bradykinesia and postural instability, while improved F-B movement amplitude correlated only with reduced postural instability. We conclude that hypometric movement amplitude, and not abnormal movement time, is the primary abnormality observed in Parkinson patients during a paced postural task. Amplitude underscaling seems antiparkinson medication-dependent and improvement correlates with favorable clinical changes in bradykinesia and postural instability scores.",
keywords = "Antiparkinson medication, Balance, Bradykinesia, Parkinson's disease, Postural control, Rigidity",
author = "Beckley, {D. J.} and Panzer, {V. P.} and Remler, {M. P.} and Ilog, {L. B.} and Bloem, {B. R.}",
year = "1995",
doi = "10.1016/0022-510X(95)00130-T",
language = "English (US)",
volume = "132",
pages = "133--138",
journal = "Journal of the Neurological Sciences",
issn = "0022-510X",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Clinical correlates of motor performance during paced postural tasks in Parkinson's disease

AU - Beckley, D. J.

AU - Panzer, V. P.

AU - Remler, M. P.

AU - Ilog, L. B.

AU - Bloem, B. R.

PY - 1995

Y1 - 1995

N2 - Bradykinesia and hypokinesia may both play a significant role in postural instability commonly seen in patients with Parkinson's disease. We investigated which factor -movement time or movement amplitude -is the more significant limiting variable in patients with Parkinson's disease during a paced postural task. We also assessed the effect of antiparkinson medication upon these movement factors and the degree of correlation with changes in clinical performance. Subjects performed paced left-right (L-R) and forward-backward (F-B) continuous weight-shifting tasks at slow, medium and fast paces. Ten Parkinson patients were studied both OFF and ON their usual antiparkinson medication. Ten age-matched healthy controls were also tested and subsequently retested on the same schedule as the patients. Movement times and amplitudes were measured and correlated with clinical changes in UPDRS motor subscores. Parkinson patients performed similar to controls with respect to movement time, but significantly displayed underscaled (reduced) movement amplitude. Movement amplitude improved after antiparkinson medication, but remained significantly less than that of controls. Improvements in L-R movement amplitude correlated with clinical improvements in bradykinesia and postural instability, while improved F-B movement amplitude correlated only with reduced postural instability. We conclude that hypometric movement amplitude, and not abnormal movement time, is the primary abnormality observed in Parkinson patients during a paced postural task. Amplitude underscaling seems antiparkinson medication-dependent and improvement correlates with favorable clinical changes in bradykinesia and postural instability scores.

AB - Bradykinesia and hypokinesia may both play a significant role in postural instability commonly seen in patients with Parkinson's disease. We investigated which factor -movement time or movement amplitude -is the more significant limiting variable in patients with Parkinson's disease during a paced postural task. We also assessed the effect of antiparkinson medication upon these movement factors and the degree of correlation with changes in clinical performance. Subjects performed paced left-right (L-R) and forward-backward (F-B) continuous weight-shifting tasks at slow, medium and fast paces. Ten Parkinson patients were studied both OFF and ON their usual antiparkinson medication. Ten age-matched healthy controls were also tested and subsequently retested on the same schedule as the patients. Movement times and amplitudes were measured and correlated with clinical changes in UPDRS motor subscores. Parkinson patients performed similar to controls with respect to movement time, but significantly displayed underscaled (reduced) movement amplitude. Movement amplitude improved after antiparkinson medication, but remained significantly less than that of controls. Improvements in L-R movement amplitude correlated with clinical improvements in bradykinesia and postural instability, while improved F-B movement amplitude correlated only with reduced postural instability. We conclude that hypometric movement amplitude, and not abnormal movement time, is the primary abnormality observed in Parkinson patients during a paced postural task. Amplitude underscaling seems antiparkinson medication-dependent and improvement correlates with favorable clinical changes in bradykinesia and postural instability scores.

KW - Antiparkinson medication

KW - Balance

KW - Bradykinesia

KW - Parkinson's disease

KW - Postural control

KW - Rigidity

UR - http://www.scopus.com/inward/record.url?scp=0029127356&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029127356&partnerID=8YFLogxK

U2 - 10.1016/0022-510X(95)00130-T

DO - 10.1016/0022-510X(95)00130-T

M3 - Article

VL - 132

SP - 133

EP - 138

JO - Journal of the Neurological Sciences

JF - Journal of the Neurological Sciences

SN - 0022-510X

IS - 2

ER -